FeesSafety
Pluang+

Parabolic Technologies Q3 revenue doubles to $4.7M with ConnectAndSell; targets cash flow breakeven in Q1 2027

Company Fundamentals
16 Nov 2026, 23:10 WIB
GlobeNewsWire
View Source
Bullish
Parabolic Technologies Q3 revenue doubles to $4.7M with ConnectAndSell; targets cash flow breakeven in Q1 2027

Parabolic Technologies reported Q3 2026 revenue of $4.7 million, a 106% increase driven by the acquisition of ConnectAndSell. The company used proceeds from a public offering to repay $11.6 million in debt early, improving its financial position. Despite a net loss of $6.4 million, Parabolic expects to reach cash flow breakeven by Q1 2027 and generate positive cash flow from Q2 2027 onward, supported by cost reductions and revenue growth from ConnectAndSell.

Parabolic Technologies' Q3 2026 financial results provide context for readers. For those following the Technology sector, 26 of 150 US stocks traded on Pluang rose while 123 fell as of Nov 17, 2026 03:21 WIB. Notable movers include IREN at USD 16.52 with a 9.08% decline and QBTS at USD 8.72 down 8.79%.

More News

Disney Q4 outlook strong with 50%+ EPS growth and streaming as key driver

Disney Q4 outlook strong with 50%+ EPS growth and streaming as key driver

Disney's fiscal Q4 report, due November 17, is expected to show strong growth with analysts forecasting over 50% earnings per share (EPS) growth and more than 12% revenue increase. Streaming revenue rose 11% last quarter with margins hitting double d...

Company Fundamentals
Bullish
2 hours ago
Infoblox launches Australia realm on AWS for local DDI management and security.

Infoblox launches Australia realm on AWS for local DDI management and security.

Infoblox has launched a new Australia realm on Amazon Web Services (AWS) in the Sydney region, providing Australian government agencies and enterprises a local option for managing DNS, DHCP, and IP address management (DDI) with enhanced security. Thi...

Market News
Bullish
2 hours ago
European Commission approves RASONQUE for metastatic pancreatic cancer treatment

European Commission approves RASONQUE for metastatic pancreatic cancer treatment

The European Commission has approved RASONQUE (daraxonrasib), the first broad RAS-targeted oral medicine for adults with metastatic pancreatic adenocarcinoma who have had prior systemic therapy. This approval covers patients with or without identifie...

Market News
Bullish
3 hours ago
SPIE acquires Duflex to boost industrial automation and robotics in the Netherlands.

SPIE acquires Duflex to boost industrial automation and robotics in the Netherlands.

SPIE, a European leader in multi-technical services, has acquired Dutch company Duflex B.V. to enhance its industrial automation, machine building, and robotics capabilities. Duflex, with 26 employees and €8 million revenue in 2025, specializes in ta...

Company Fundamentals
Bullish
4 hours ago
Rexel repurchases 3,878 own shares at an average price of €34.67 from Nov 9-13, 2026

Rexel repurchases 3,878 own shares at an average price of €34.67 from Nov 9-13, 2026

Rexel Développement SAS disclosed that it repurchased a total of 3,878 of its own shares between November 9 and November 13, 2026. The average purchase price during this period was approximately €34.67 per share. This buyback is part of an authorized...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App